Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/20.500.12421/517
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVera, Omaira-
dc.contributor.authorde Brito, Paula Brelas-
dc.contributor.authorAlbrecht, Letusa-
dc.contributor.authorMartins-Campos, Keillen Monick-
dc.contributor.authorP. Pimenta, Paulo F.-
dc.contributor.authorMonteiro, Wuelton M.-
dc.contributor.authorG. Lacerda, Marcus V.-
dc.contributor.authorP. Lopes, Stefanie C.-
dc.contributor.authorM. Costa, Fabio T.-
dc.date.accessioned2019-08-08T05:54:32Z-
dc.date.available2019-08-08T05:54:32Z-
dc.date.issued2015-
dc.identifier.issn1098-6596-
dc.identifier.urihttps://repository.usc.edu.co:8443/xmlui/handle/123456789/517-
dc.description.abstractSignificant progress toward the control of malaria has been achieved, especially regarding Plasmodium falciparum infections. However, the unique biology of Plasmodium vivax hampers current control strategies. The early appearance of P. vivax gametocytes in the peripheral blood and the impossibility of culturing this parasite are major drawbacks. Using blood samples from 40 P. vivax-infected patients, we describe here a methodology to purify viable gametocytes and further infect anophelines. This method opens new avenues to validate transmission-blocking strategies.en_US
dc.language.isoesen_US
dc.publisherAntimicrobial Agents and Chemotherapyen_US
dc.titlePurification Methodology for Viable and Infective Plasmodium vivax Gametocytes That Is Compatible with Transmission-Blocking Assays.en_US
dc.typeArticleen_US
Appears in Collections:Producción Científica

Files in This Item:
File Description SizeFormat 
Purification Methodology for Viable and Infective Plasmodium vivax.pdf983.67 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.